EDGAR Filing Documents for 0001047469-19-006014

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001047469-19-006014

Filing Date

2019-10-31

Accepted

2019-10-31 17:25:10

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	a2239974zs-3.htm	S-3	275169
2	EX-4.3	a2239974zex-4_3.htm	EX-4.3	485437
3	EX-4.5	a2239974zex-4_5.htm	EX-4.5	164218
4	EX-4.6	a2239974zex-4_6.htm	EX-4.6	165437
5	EX-4.7	a2239974zex-4_7.htm	EX-4.7	138536
6	EX-5.1	a2239974zex-5_1.htm	EX-5.1	31353
7	EX-23.1	a2239974zex-23_1.htm	EX-23.1	2527
8	G111729.JPG	g111729.jpg	GRAPHIC	29586
9	G238743.JPG	g238743.jpg	GRAPHIC	72668
10	G203762KMI001.GIF	g203762kmi001.gif	GRAPHIC	1275
	Complete submission text file	0001047469-19-006014.txt		1406841

Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160

Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170

Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)